Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Reinstates Overweight on Ameris, Announces $62 Price Target

Piper Sandler analyst Casey Orr Whitman reinstates Ameris (NASDAQ:ABCB) with a Overweight and announces $62 price target.

byBenzinga Newsdesk

December 5, 2022

1 minute read

Piper Sandler analyst Casey Orr Whitman reinstates Ameris (NASDAQ:ABCB) with a Overweight and announces $62 price target.

RBC Capital Maintains Outperform on Cerence, Lowers Price Target to $95

By Benzinga Newsdesk

Today, 3:49 AM

RBC Capital analyst Joseph Spak maintains Cerence (NASDAQ:CRNC) with a Outperform and lowers the price target from $110 to $95.

CRNC

Iovance Biotherapeutics Acquires Clinigen’s IL-2 Product For Upfront £166.7M

By Vandana Singh

Today, 3:49 AM

Iovance Biotherapeutics Inc (NASDAQ:IOVA) has agreed to acquire worldwide rights to Proleukin (aldesleukin), an interleukin-2 (IL-2) product, from Clinigen Limited. Iovance expects…

IOVA

Recap: Lamar Advertising Q4 Earnings

By Benzinga Insights

Today, 3:49 AM

Lamar Advertising (NASDAQ:LAMR) reported its Q4 earnings results on Friday, February 25, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

LAMR